Reina Sikkema

Dr. Reina Sikkema

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in The Lancet Infectious Diseases
Verified
Journal Article
Open access
RSReina Sikkema
Reina Sikkema
SPSuzan D Pas
Suzan D Pas
DNDavid F Nieuwenhuijse
David F Nieuwenhuijse
ÁOÁine O'TOole
Áine O'TOole
JVJaco Verweij
Jaco Verweij
MKMarion P G Koopmans
Marion P G Koopmans
10 days after the first reported case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the Netherlands (on Feb 27, 2020), 55 (4%) of 1497 health-care workers in nine hospitals located in the south of the Netherlands had tested positive for SARS-CoV-2 RNA. We aimed to gain insight in possible sources of infection in health-care workers. We did a cross-sectional study at three of the nine hospitals located in the south of the Netherlands. We screened health-care workers at the participating hospitals for SARS-CoV-2 infection, based on clinical symptoms (fever or mild respiratory symptoms) in the 10 days before screening. We obtained epidemiological data through structured interviews with health-care workers and combined this information with data from whole-genome sequencing of SARS-CoV-2 in clinical samples taken from health-care workers and patients. We did an in-depth analysis of sources and modes of transmission of SARS-CoV-2 in health-care workers and patients. Between March 2 and March 12, 2020, 1796 (15%) of 12 022 health-care workers were screened, of whom 96 (5%) tested positive for SARS-CoV-2. We obtained complete and near-complete genome sequences from 50 health-care workers and ten patients. Most sequences were grouped in three clusters, with two clusters showing local circulation within the region. The noted patterns were consistent with multiple introductions into the hospitals through community-acquired infections and local amplification in the community. Although direct transmission in the hospitals cannot be ruled out, our data do not support widespread nosocomial transmission as the source of infection in patients or health-care workers. EU Horizon 2020 (RECoVer, VEO, and the European Joint Programme One Health METASTAVA), and the National Institute of Allergy and Infectious Diseases, National Institutes of Health.

1 November 2010 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
BABernadette Abela-Ridder
Bernadette Abela-Ridder
RSReina Sikkema
Reina Sikkema
RHRudy A. Hartskeerl
Rudy A. Hartskeerl

1 August 2016 in Emerging Infectious Diseases
Verified
Journal Article
Open access
Yongyi ShenYongyi Shen
Yongyi Shen
CKChang-Wen Ke
Chang-Wen Ke
QLQian Li
Qian Li
RYRun-Yu Yuan
Run-Yu Yuan
DXDan Xiang
Dan Xiang
MLMing Liao
Ming Liao

8 October 2020 in Eurosurveillance
Verified
Journal Article
Open access
RSReina Sikkema
Reina Sikkema
MSMaarten Schrama
Maarten Schrama
TBTijs van Den Berg
Tijs van Den Berg
JMJolien Morren
Jolien Morren
EMEmmanuelle Munger
Emmanuelle Munger
HJHenk van der Jeugd
Henk van der Jeugd
On 22 August, a common whitethroat in the Netherlands tested positive for West Nile virus lineage 2. The same bird had tested negative in spring. Subsequent testing of Culex mosquitoes collected in August and early September in the same location generated two of 44 positive mosquito pools, providing first evidence for enzootic transmission in the Netherlands. Sequences generated from the positive mosquito pools clustered with sequences that originate from Germany, Austria and the Czech Republic.

21 February 2019 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
RSReina Sikkema
Reina Sikkema
EFE. A. B. A. Farag
E. A. B. A. Farag
Md. Mazharul IslamMd. Mazharul Islam
Md. Mazharul Islam
MAMuzzamil Atta
Muzzamil Atta
CRC. B. E. M. Reusken
C. B. E. M. Reusken
MKMarion P.G. Koopmans
Marion P.G. Koopmans
Dromedary camels have been shown to be the main reservoir for human Middle East respiratory syndrome (MERS) infections. This systematic review aims to compile and analyse all published data on MERS-coronavirus (CoV) in the global camel population to provide an overview of current knowledge on the distribution, spread and risk factors of infections in dromedary camels. We included original research articles containing laboratory evidence of MERS-CoV infections in dromedary camels in the field from 2013 to April 2018. In general, camels only show minor clinical signs of disease after being infected with MERS-CoV. Serological evidence of MERS-CoV in camels has been found in 20 countries, with molecular evidence for virus circulation in 13 countries. The seroprevalence of MERS-CoV antibodies increases with age in camels, while the prevalence of viral shedding as determined by MERS-CoV RNA detection in nasal swabs decreases. In several studies, camels that were sampled at animal markets or quarantine facilities were seropositive more often than camels at farms as well as imported camelsvs.locally bred camels. Some studies show a relatively higher seroprevalence and viral detection during the cooler winter months. Knowledge of the animal reservoir of MERS-CoV is essential to develop intervention and control measures to prevent human infections.

1 January 2016 in Infection Ecology & Epidemiology
Verified
Journal Article
Open access
PDF file
RSReina Sikkema
Reina Sikkema
MKMarion P.G. Koopmans
Marion P.G. Koopmans
One Health training and research activities in Western Europe